Cargando…
The impact of COVID-19 on people who inject drugs in New York City: increased risk and decreased access to services
BACKGROUND: While people who inject drugs (PWID) are vulnerable to the adverse outcomes of events like COVID-19, little is known regarding the impact of the current pandemic on PWID. We examine how COVID-19 has affected PWID in New York City across four domains: substance use, risk behaviors, mental...
Autores principales: | Aponte-Melendez, Yesenia, Mateu-Gelabert, Pedro, Fong, Chunki, Eckhardt, Benjamin, Kapadia, Shashi, Marks, Kristen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611635/ https://www.ncbi.nlm.nih.gov/pubmed/34819070 http://dx.doi.org/10.1186/s12954-021-00568-3 |
Ejemplares similares
-
“Treated like a Human Being”: perspectives of people who inject drugs attending low-threshold HCV treatment at a syringe service program in New York City
por: Kapadia, Shashi N., et al.
Publicado: (2023) -
917. Accessible HCV Care for People Who Inject Drugs: Randomized Clinical Trial Comparing Low-Threshold Treatment at a Syringe Service Program Versus Facilitated Referral
por: Eckhardt, Benjamin, et al.
Publicado: (2021) -
Rapid Treatment Initiation for Hepatitis C in Young People Who Inject Drugs: The Seek, Test, and Rapid Treatment Randomized Trial
por: Eckhardt, Benjamin, et al.
Publicado: (2022) -
911. Rapid Hepatitis C Treatment Initiation in Young People Who Inject Drugs: Final Results from the HCV-Seek, Test and Rapid Treatment (HCV-ST&RT) Randomized Pilot Clinical Trial
por: Eckhardt, Benjamin, et al.
Publicado: (2021) -
2216. Hepatitis C Treatment Wanted Yet Not Received: Barriers to Receiving HCV Treatment Among People Who Inject Drugs
por: Kapadia, Shashi, et al.
Publicado: (2018)